c-ABL-IN-3, a highly effective c-Abl inhibitor, exhibits promising potential for studying neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinsons disease (PD), as well as cancer [1]. The activation of c-Abl has been strongly implicated in a range of diseases, notably cancer [1]. It offers valuable opportunities for research in these fields [1].
Molecular Weight:
376.29
CAS Number:
[2626934-64-1]
Formula:
C17H11F3N4O3
Target:
Others|||Bcr-Abl
T61546
* VAT and and shipping costs not included. Errors and price changes excepted
